# A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer

> **NCT06296706** · PHASE3 · RECRUITING · sponsor: **CSPC ZhongQi Pharmaceutical Technology Co., Ltd.** · enrollment: 630 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Docetaxel for injection (Albumin-bound)
- **DRUG:** Taxotere (docetaxel)

## Key facts

- **NCT ID:** NCT06296706
- **Lead sponsor:** CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-27
- **Primary completion:** 2026-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 630 (ESTIMATED)
- **Last updated:** 2024-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06296706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06296706, "A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT06296706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*